Loading viewer...
investor_presentation
Format: PDF investor_presentation
Third Quarter 2021 Financial Results Presentation November 2, 2021
Third Quarter 2021 Financial Results Presentation
November 2, 2021Forward -Looking Statements
2Note: This presentation contains product names, trademarks and registered trademarks are property of their respective ownersIn addition to historical information, the statements set forth in this presentation include forward -looking statements includin g, without limitation, statements
concerning the Company’s expected future financial performance (including the Company's financial outlook for 2021) and expec tations for profitability,
revenue (including expectations for future milestones and royalty growth), operating income, expenses and earnings -per-share, an d to potentially expand the
Company's platform through acquisitions. Forward -looking statements regarding the Company’s ENHANZE®drug delivery technology may include the
possible activity, benefits and attributes of ENHANZE®, the possible method of action of ENHANZE®, its potential application to aid in the dispersion and
absorption of other injected therapeutic drugs and facilitating more rapid delivery and administration of larger volumes of i njectable medications through
subcutaneous delivery and potentially lowering the treatment burden for patients. Forward -looking statements regarding the Compa ny's ENHANZE®business
may include potential growth driven by our partners' development and commercialization efforts (including anticipated new cli nical trial starts and
ENHANZE®product launches), projections for future sales revenue of our collaborators’ products, potential new ENHANZE®collaborations and collaborative
targets and potential approvals of new ENHANZE®products. These forward -looking statements are typically, but not always, identified through use of the
words "believe," "enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict," "probable," "poten tial," "possible," "should," "continue," and
other words of similar meaning and involve risk and uncertainties that could cause actual results to differ materially from t hose in the forward -looking
statements. Actual results could differ materially from the expectations contained in these forward -looking statements as a resu lt of several factors, including
unexpected levels of revenues (including royalty and milestone revenue received from our collaboration partners), expenditure s and costs, unexpected
delays in the execution of the Company's planned platform expansion, unexpected results or delays in the growth of the Company’ s ENHANZE®business, or in
the development, regulatory review or commercialization of ENHANZE®products, including any potential delays caused by the current COVID -19 global
pandemic, regulatory approval requirements, unexpected adverse events or patient outcomes and competitive conditions. These a nd other factors that may
result in differences are discussed in greater detail in the Company's most recently filed Annual Report on Form 10 -K and Quarte rly Reports on Form 10 -Q filed
Preview truncated — download the full document for the complete content.
conference
20 Pages
investor_presentation
21 Pages
First Interstate BancSystem
Honeywell International Investor Presentation — September 2018
investor_presentationinvestor_presentation
18 Pages
Honeywell International Inc.